A detailed history of Mattern Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mattern Capital Management, LLC holds 10,913 shares of LLY stock, worth $11.1 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
10,913
Previous 7,240 50.73%
Holding current value
$11.1 Million
Previous $5.64 Million 47.55%
% of portfolio
1.03%
Previous 0.71%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$625.65 - $812.69 $2.3 Million - $2.99 Million
3,673 Added 50.73%
10,913 $8.33 Million
Q2 2025

Jul 21, 2025

BUY
$713.71 - $898.95 $519,580 - $654,435
728 Added 11.18%
7,240 $5.64 Million
Q1 2025

Apr 23, 2025

BUY
$725.72 - $929.72 $4.14 Million - $5.3 Million
5,705 Added 706.94%
6,512 $5.38 Million
Q4 2024

Feb 03, 2025

BUY
$727.2 - $932.06 $379,598 - $486,535
522 Added 183.16%
807 $623,000
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $168,777 - $225,799
285 New
285 $221,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mattern Capital Management, LLC Portfolio

Follow Mattern Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mattern Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mattern Capital Management, LLC with notifications on news.